GE Healthcare's Stress Agent Rapiscan Approved for use in Stress Cardiac Magnetic Resonance Imaging

Already used in single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) for adult patients, Rapiscan is now approved for use in stress cardiac magnetic resonance imaging (CMR)

Related Keywords

Mexico ,Canada ,Mark Hibberd ,Gianluca Pontone ,Rapiscan Regadenoson ,Monzino Cardiology Center At University Of Milan ,Cardiovascular Imaging Department ,European Society Of Cardiology ,European Medicines Agency ,Ge Healthcare ,Magnetic Resonance Imaging ,Computed Tomography ,Positron Emission Tomography ,Monzino Cardiology Center ,Chief Medical Officer ,Pharmaceutical Diagnostics ,